Immune Response and Prognosis of Chronic Kidney Disease Patients Undergoing Hemodialysis Against COVID-19: A Systematic Review

Nurul Hanifa; Riri Andri Muzasti

doi:10.14710/dmj.v11i3.34232

DOI: https://doi.org/10.14710/dmj.v11i3.34232

Immune Response and Prognosis of Chronic Kidney Disease Patients Undergoing Hemodialysis Against COVID-19: A Systematic Review

*Nurul Hanifa - Undergraduate Program, Faculty of Medicine, Sumatera Utara University, Jl. Dr. Mansyur, Medan, Indonesia 20155, Indonesia

Riri Andri Muzasti - Division of Nephrology and Hypertension, Department of Internal Medicine Faculty of Medicine Universitas Sumatera Utara, Jl. Dr. Mansyur, Medan, Indonesia 20155, Indonesia

BibTex Citation Data :

@article{dmj34232,
    author = {Nurul Hanifa and Riri Muzasti},
    title = {Immune Response and Prognosis of Chronic Kidney Disease Patients Undergoing Hemodialysis Against COVID-19: A Systematic Review},
    journal = {Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal)},
  volume = {11},
    number = {3},
    year = {2022},
    keywords = {chronic kidney disease; COVID-19; immune response; mortality},
    abstract = {  Background:  Chronic kidney disease (CKD) patients are characterized by immune response dysfunction which increased susceptibility to infections. CKD is one of the Coronavirus disease-2019 (COVID-19) comorbidity that generally has a poor clinical outcome and patients undergoing hemodialysis had a 50% hospitalization rate and 20%-30% mortality rate. Seroconversion after confirmation of COVID-19 infection is close to 100% in the dialysis population, but the durability of the immune response and the extent as a protection against infection remains unclear. This study aimed to determine the immune response and prognosis of CKD patients undergoing hemodialysis against COVID-19.   Objective:  To determine immune response and prognosis of CKD patients undergoing hemodialysis against COVID-19.   Methods  :  This is a systematic review study that used literature sourced from online journal databases on Google Scholar, PubMed, Cochrane, and Clinical Key sites. Literature that has passed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) staging and the journal quality review based on the Newcastle-Ottawa Scale (NOS) assessment is then synthesized qualitatively and presented systematically.   Results:  Based on the data analysis, there were positive immune responses in 460 of 735 (62.6%) CKD patients undergoing hemodialysis against COVID-19 and a higher mortality rate (10.5%) than the control group (6.9%).   Conclusion:  The immune response and prognosis of CKD patients undergoing hemodialysis against COVID-19 were worse than the control group. Therefore, COVID-19 vaccination should be prioritized in CKD patients undergoing hemodialysis. },
   issn = {2540-8844},   pages = {175--180}  doi = {10.14710/dmj.v11i3.34232},
    url = {https://ejournal3.undip.ac.id/index.php/medico/article/view/34232}
}

Citation Format:

Abstract

Background: Chronic kidney disease (CKD) patients are characterized by immune response dysfunction which increased susceptibility to infections. CKD is one of the Coronavirus disease-2019 (COVID-19) comorbidity that generally has a poor clinical outcome and patients undergoing hemodialysis had a 50% hospitalization rate and 20%-30% mortality rate. Seroconversion after confirmation of COVID-19 infection is close to 100% in the dialysis population, but the durability of the immune response and the extent as a protection against infection remains unclear. This study aimed to determine the immune response and prognosis of CKD patients undergoing hemodialysis against COVID-19.

Objective: To determine immune response and prognosis of CKD patients undergoing hemodialysis against COVID-19.

Methods: This is a systematic review study that used literature sourced from online journal databases on Google Scholar, PubMed, Cochrane, and Clinical Key sites. Literature that has passed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) staging and the journal quality review based on the Newcastle-Ottawa Scale (NOS) assessment is then synthesized qualitatively and presented systematically.

Results: Based on the data analysis, there were positive immune responses in 460 of 735 (62.6%) CKD patients undergoing hemodialysis against COVID-19 and a higher mortality rate (10.5%) than the control group (6.9%).

Conclusion: The immune response and prognosis of CKD patients undergoing hemodialysis against COVID-19 were worse than the control group. Therefore, COVID-19 vaccination should be prioritized in CKD patients undergoing hemodialysis.

Note: This article has supplementary file(s).

Fulltext View|Download | Ethics Form

Ethics Form

Subject
Type	Ethics Form
	Download (573KB) Indexing metadata

Keywords: chronic kidney disease; COVID-19; immune response; mortality

Article Metrics:

Article Info

Section: Original Articles

Language : EN

In Vol 11, No 3 (2022): JURNAL KEDOKTERAN DIPONEGORO (DIPONEGORO MEDICAL JOURNAL)

Recent articles

NURSES’ SLEEP QUALITY AND QUALITY OF LIFE DURING THE COVID-19 PANDEMIC: ANALYSIS OF CORRELATION AND DIFFERENCES IN THE RAJAWALI ISOLATION AND NON-ISOLATION WARDS Factors Affecting Patient Adherence to Pharmacological Therapy in Gout Arthritis and Hyperuricemia THE RELATIONSHIP BETWEEN WAIST-HIP RATIO AND 60-METER RUNNING SPEED Studies on students of the Faculty of Medicine, Diponegoro University More recent articles

Last update:

No citation recorded.

Last update:

No citation recorded.

Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC-BY-NC-SA) that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal. - Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).